Unité de Fabrication des Médicaments S.A (BVMT:UMED)

BVMT:UMED Revenue

Unité de Fabrication des Médicaments S.A had revenue of 66.21M TND in the half year ending June 30, 2024, with 55.87% growth. This brings the company's revenue in the last twelve months to 140.96M, up 22.43% year-over-year. In the year 2023, Unité de Fabrication des Médicaments S.A had annual revenue of 136.00M with 41.14% growth.

• Revenue (ttm): 140.96M
• Revenue Growth: +22.43%
• P/S Ratio: 1.66
• Revenue / Employee: 246.44K
• Employees: 572
• Market Cap: 233.60M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	136.00M	39.64M	41.14%
Dec 31, 2022	96.36M	11.85M	14.02%
Dec 31, 2021	84.51M	-6.53M	-7.18%
Dec 31, 2020	91.04M	-16.16M	-15.07%
Dec 31, 2019	107.21M	20.12M	23.10%